1. Home
  2. HALO vs SAIA Comparison

HALO vs SAIA Comparison

Compare HALO & SAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HALO
  • SAIA
  • Stock Information
  • Founded
  • HALO 1998
  • SAIA 1924
  • Country
  • HALO United States
  • SAIA United States
  • Employees
  • HALO N/A
  • SAIA N/A
  • Industry
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • SAIA Trucking Freight/Courier Services
  • Sector
  • HALO Health Care
  • SAIA Industrials
  • Exchange
  • HALO Nasdaq
  • SAIA Nasdaq
  • Market Cap
  • HALO 7.4B
  • SAIA 8.8B
  • IPO Year
  • HALO N/A
  • SAIA 2002
  • Fundamental
  • Price
  • HALO $65.87
  • SAIA $260.62
  • Analyst Decision
  • HALO Buy
  • SAIA Buy
  • Analyst Count
  • HALO 9
  • SAIA 18
  • Target Price
  • HALO $63.78
  • SAIA $393.44
  • AVG Volume (30 Days)
  • HALO 2.0M
  • SAIA 1.0M
  • Earning Date
  • HALO 05-06-2025
  • SAIA 04-25-2025
  • Dividend Yield
  • HALO N/A
  • SAIA N/A
  • EPS Growth
  • HALO 55.40
  • SAIA N/A
  • EPS
  • HALO 3.76
  • SAIA 11.99
  • Revenue
  • HALO $1,084,306,000.00
  • SAIA $3,241,874,000.00
  • Revenue This Year
  • HALO $20.06
  • SAIA $9.72
  • Revenue Next Year
  • HALO $24.20
  • SAIA $8.69
  • P/E Ratio
  • HALO $17.56
  • SAIA $21.74
  • Revenue Growth
  • HALO 25.64
  • SAIA 8.95
  • 52 Week Low
  • HALO $41.28
  • SAIA $229.12
  • 52 Week High
  • HALO $70.51
  • SAIA $624.55
  • Technical
  • Relative Strength Index (RSI)
  • HALO 58.99
  • SAIA 39.09
  • Support Level
  • HALO $58.38
  • SAIA $251.67
  • Resistance Level
  • HALO $70.51
  • SAIA $271.16
  • Average True Range (ATR)
  • HALO 2.50
  • SAIA 15.74
  • MACD
  • HALO 0.88
  • SAIA 0.94
  • Stochastic Oscillator
  • HALO 64.61
  • SAIA 23.62

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About SAIA Saia Inc.

Saia ranks among the 10 largest less-than-truckload carriers in the United States, with more than 200 facilities and a fleet of more than 6,500 tractors and 26,000 trailers. As a national LTL carrier, the firm offers time-definite and expedited options for shipments ranging between 100 and 10,000 pounds. Saia ranks among the top-tier providers in terms of profitability.

Share on Social Networks: